inspection in the Dockets Management Branch (HFA–305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. It is unnecessary to submit copies and reprints of the reports from the listed published literature. We invite applicants to submit any other pertinent studies and literature of which they are aware.

VI. Published Literature

The published literature we have relied on in making our recommendations will be placed on display in the Dockets Management Branch (address above) and may be seen by interested persons between 9 a.m. and 4 p.m., Monday through Friday. A list of this published literature will be on display in the Dockets Management Branch and on the Internet at

www.fda.gov/cder/drug/infopage/penG...doxy/bibliolist.htm.

Dated: October 26, 2001

Bernard A. Schwetz, Acting Principal Deputy Commissioner

[FR Doc. 01–27493 Filed 10–29–01; 4:35 pm]

SOURCE: Federal Register/Vol. 66, No. 213/Friday, November 2, 2001/Notices



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement